314 related articles for article (PubMed ID: 20065960)
1. Bifidobacterium as an oral delivery carrier of oxyntomodulin for obesity therapy: inhibitory effects on food intake and body weight in overweight mice.
Long RT; Zeng WS; Chen LY; Guo J; Lin YZ; Huang QS; Luo SQ
Int J Obes (Lond); 2010 Apr; 34(4):712-9. PubMed ID: 20065960
[TBL] [Abstract][Full Text] [Related]
2. [Expression of oxyntomodulin in bifidobacteria and effect of oxyntomodulin-transformed bifidobacteria on the body weight of obese mice].
Long RT; Zeng WS; Luo SQ; Guo J; Lin YZ; Huang QS
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Sep; 29(9):1796-8. PubMed ID: 19778793
[TBL] [Abstract][Full Text] [Related]
3. Bifidobacterium as an oral delivery carrier of interleukin-12 for the treatment of Coxsackie virus B3-induced myocarditis in the Balb/c mice.
Yu Z; Huang Z; Sao C; Huang Y; Zhang F; Yang J; Lian J; Zeng Z; Luo W; Zeng W; Deng Q
Int Immunopharmacol; 2012 Jan; 12(1):125-30. PubMed ID: 22088614
[TBL] [Abstract][Full Text] [Related]
4. Treatment of mice with dextran sulfate sodium-induced colitis with human interleukin 10 secreted by transformed Bifidobacterium longum.
Yao J; Wang JY; Lai MG; Li YX; Zhu HM; Shi RY; Mo J; Xun AY; Jia CH; Feng JL; Wang LS; Zeng WS; Liu L
Mol Pharm; 2011 Apr; 8(2):488-97. PubMed ID: 21271712
[TBL] [Abstract][Full Text] [Related]
5. Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats.
Dakin CL; Small CJ; Park AJ; Seth A; Ghatei MA; Bloom SR
Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1173-7. PubMed ID: 12388165
[TBL] [Abstract][Full Text] [Related]
6. Oxyntomodulin suppresses appetite and reduces food intake in humans.
Cohen MA; Ellis SM; Le Roux CW; Batterham RL; Park A; Patterson M; Frost GS; Ghatei MA; Bloom SR
J Clin Endocrinol Metab; 2003 Oct; 88(10):4696-701. PubMed ID: 14557443
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice.
Matsumoto T; Ishikawa H; Tateda K; Yaeshima T; Ishibashi N; Yamaguchi K
J Appl Microbiol; 2008 Mar; 104(3):672-80. PubMed ID: 17927741
[TBL] [Abstract][Full Text] [Related]
8. Peripheral oxyntomodulin reduces food intake and body weight gain in rats.
Dakin CL; Small CJ; Batterham RL; Neary NM; Cohen MA; Patterson M; Ghatei MA; Bloom SR
Endocrinology; 2004 Jun; 145(6):2687-95. PubMed ID: 15001546
[TBL] [Abstract][Full Text] [Related]
9. Oral immunization of mice using Bifidobacterium longum expressing VP1 protein from enterovirus 71.
Yu Z; Huang Z; Sao C; Huang Y; Zhang F; Ma G; Chen Z; Zeng Z; Qiwen D; Zeng W
Arch Virol; 2013 May; 158(5):1071-7. PubMed ID: 23275129
[TBL] [Abstract][Full Text] [Related]
10. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
11. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
[TBL] [Abstract][Full Text] [Related]
12. Oxyntomodulin increases the concentrations of insulin and glucose in plasma but does not affect ghrelin secretion in Holstein cattle under normal physiological conditions.
ThanThan S; Zhao H; Yannaing S; Ishikawa T; Kuwayama H
Domest Anim Endocrinol; 2010 Oct; 39(3):163-70. PubMed ID: 20705414
[TBL] [Abstract][Full Text] [Related]
13. DPP-IV-resistant, long-acting oxyntomodulin derivatives.
Santoprete A; Capitò E; Carrington PE; Pocai A; Finotto M; Langella A; Ingallinella P; Zytko K; Bufali S; Cianetti S; Veneziano M; Bonelli F; Zhu L; Monteagudo E; Marsh DJ; Sinharoy R; Bianchi E; Pessi A
J Pept Sci; 2011 Apr; 17(4):270-80. PubMed ID: 21294225
[TBL] [Abstract][Full Text] [Related]
14. Oxyntomodulin and glicentin are potent inhibitors of the fed motility pattern in small intestine.
Pellissier S; Sasaki K; Le-Nguyen D; Bataille D; Jarrousse C
Neurogastroenterol Motil; 2004 Aug; 16(4):455-63. PubMed ID: 15306001
[TBL] [Abstract][Full Text] [Related]
15. Intracerebroventricular administration of chicken oxyntomodulin suppresses food intake and increases plasma glucose and corticosterone concentrations in chicks.
Honda K; Saneyasu T; Yamaguchi T; Shimatani T; Aoki K; Nakanishi K; Kamisoyama H
Neurosci Lett; 2014 Apr; 564():57-61. PubMed ID: 24530259
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of live Bifidobacterium substrains isolated from healthy centenarians enhanced immune function in BALB/c mice.
Yang HY; Liu SL; Ibrahim SA; Zhao L; Jiang JL; Sun WF; Ren FZ
Nutr Res; 2009 Apr; 29(4):281-9. PubMed ID: 19410981
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
19. Central oxyntomodulin causes anorexigenic effects associated with the hypothalamus and alimentary canal in chicks (Gallus gallus).
Cline MA; Bowden CN; Nandar W; Rogers JO
Comp Biochem Physiol A Mol Integr Physiol; 2008 Apr; 149(4):405-10. PubMed ID: 18313343
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
